HedgeChatter

  • Home /
  • Tag Archives

NBS

NeoStem Receives Notification of $1.2 million NIH Grant Award for First Clinical Study of VSELTM Technology in Humans

[at noodls] – Nov 20 2012 New York, Nov. 20, 2012 – NeoStem, Inc. (NYSE:NBS) (NeoStem or the Company), an emerging leader in the fast growing cell therapy industry, today announced that it has … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboard […]

November 20, 2012 Bystocknews , Comments Off on NeoStem Receives Notification of $1.2 million NIH Grant Award for First Clinical Study of VSELTM Technology in Humans read more

NeoStem to Present at Multiple Conferences in November

[at noodls] – Oct 31 2012 NeoStem, Inc. (NYSE MKT:NBS) (NeoStem or the Company), an emerging leader in the fast growing cell therapy market, today announced that Company management and management … moreView todays social media effects on NBSView the latest stocks trending across Twitter. Click to view dashboard […]

October 31, 2012 Bystocknews , Comments Off on NeoStem to Present at Multiple Conferences in November read more